NZ746608A - Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof - Google Patents
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereofInfo
- Publication number
- NZ746608A NZ746608A NZ746608A NZ74660811A NZ746608A NZ 746608 A NZ746608 A NZ 746608A NZ 746608 A NZ746608 A NZ 746608A NZ 74660811 A NZ74660811 A NZ 74660811A NZ 746608 A NZ746608 A NZ 746608A
- Authority
- NZ
- New Zealand
- Prior art keywords
- salt
- ylamino
- piperazin
- pyrrolo
- pyridin
- Prior art date
Links
- RHXHGRAEPCAFML-UHFFFAOYSA-N 7-cyclopentyl-n,n-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide Chemical compound N1=C2N(C3CCCC3)C(C(=O)N(C)C)=CC2=CN=C1NC(N=C1)=CC=C1N1CCNCC1 RHXHGRAEPCAFML-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- NHANOMFABJQAAH-UHFFFAOYSA-N butanedioic acid;7-cyclopentyl-n,n-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide Chemical compound OC(=O)CCC(O)=O.N1=C2N(C3CCCC3)C(C(=O)N(C)C)=CC2=CN=C1NC(N=C1)=CC=C1N1CCNCC1 NHANOMFABJQAAH-UHFFFAOYSA-N 0.000 abstract 2
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229950003687 ribociclib Drugs 0.000 abstract 1
- 229950010518 ribociclib succinate Drugs 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41206410P | 2010-11-10 | 2010-11-10 | |
NZ72954411 | 2011-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ746608A true NZ746608A (en) | 2020-05-29 |
Family
ID=71074418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ746608A NZ746608A (en) | 2010-11-10 | 2011-11-09 | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ746608A (en) |
-
2011
- 2011-11-09 NZ NZ746608A patent/NZ746608A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ601754A (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
MX2021012478A (en) | Crystalline forms of a bruton's tyrosine kinase inhibitor. | |
MX2020011079A (en) | Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolid in-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-c arboxamide hydrogen sulfate. | |
MY186126A (en) | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | |
NZ629432A (en) | Heterocyclyl compounds as mek inhibitors | |
PH12014501504A1 (en) | THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES | |
MX2011012337A (en) | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases. | |
NZ609957A (en) | Heterocyclic compounds and uses thereof | |
MY158193A (en) | Morpholino pyrimidines and their use in therapy | |
WO2009007749A3 (en) | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases | |
MX2012013774A (en) | Soluble guanylate cyclase activators. | |
MX2009008486A (en) | Imidazoquinolines as dual lipid kinase and mtor inhibitors. | |
TW200635899A (en) | Chemical compounds | |
GB201205669D0 (en) | Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof | |
MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
MX2012012952A (en) | 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds. | |
TN2013000324A1 (en) | 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors | |
MX2013014007A (en) | [1,3]oxazines. | |
UA104489C2 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
MX2009004908A (en) | Chemical compounds. | |
GEP20166483B (en) | Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament | |
MX2012002327A (en) | Kinase inhibitors, prodrug forms thereof and their use in therapy. | |
MX2014003194A (en) | 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase. | |
GB201302704D0 (en) | Therapeutic compounds | |
AU2010275640A8 (en) | Benzoquinolizinium salt derivatives as anticancer agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 09 NOV 2021 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20200902 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 NOV 2022 BY CPA GLOBAL Effective date: 20211022 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 NOV 2023 BY CPA GLOBAL Effective date: 20221020 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 NOV 2024 BY CPA GLOBAL Effective date: 20231019 |